Search results
Want $1,000 in Dividend Income? Here's How Much You'd Have to Invest in Pfizer Stock | The Motley...
The Motley Fool· 3 days agoPfizer (PFE -0.21%) stock has struggled over the past year, losing around 28% of its value. Its...
FDA delays decision date for Moderna's RSV vaccine - Boston Business Journal
The Business Journals· 6 days agoJust days before its deadline, the U.S. Food and Drug Administration says it's giving itself more...
Moderna (MRNA) Falls as FDA Extends Review Time for RSV Vaccine
Zacks· 3 days agoFree Report) were down 4.4% on May 10 after the company announced that the FDA has delayed the review timeline for its mRNA-based, respiratory syncytial virus (RSV) vaccine, mRNA-1345. Moderna ...